Resource table
| Unique stem cell line identifier | NCATS-CL39075 |
| Alternative name(s) of stem cell line | HT594C |
| Institution | National Institutes of Health National Center for Advancing Translational Sciences Bethesda, Maryland, USA |
| Contact information of distributor | Dr. Wei Zheng Wei.Zheng@nih.gov |
| Type of cell line | iPSC |
| Origin | Human |
| Additional origin info | Age: 2-year-old Sex: Male Ethnicity: Caucasian |
| Cell Source | Skin fibroblasts |
| Clonality | Clonal |
| Method of reprogramming | Integration-free Sendai viral vectors |
| Genetic Modification | No |
| Type of Modification | Hereditary |
| Associated disease | NGLY1 Deficiency |
| Gene/Locus | NGLY1 gene, located at 3p24.2, mutations L318P and R390P |
| Method of modification | N/A |
| Name of transgene or resistance | N/A |
| Inducible/constitutive system | N/A |
| Date archived/stock date | 4/20/2020 |
| Cell line repository/bank | N/A |
| Ethical approval | NIGMS Informed Consent Form was obtained from patient at time of sample submission. Confidentiality Certificate: CC-GM-15-004 |